Article Information
History
- April 16, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Joshua G. Petrie, PhD1,*,
- Jennifer P. King, MPH1,
- David L. McClure, PhD1,
- Melissa A. Rolfes, PhD2,
- Jennifer K. Meece1,
- Edward A. Belongia, MD1 and
- Huong Q. McLean, PhD1
- 1Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA
- 2Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
- ↵*CORRESPONDING AUTHOR:
Joshua G. Petrie, Marshfield Clinic Research Institute (ML2), 1000 N Oak Avenue, Marshfield, WI 54449, USA., Email: petrie.joshua{at}marshfieldresearch.org
Posted April 16, 2022.
Effectiveness of COVID-19 mRNA vaccine booster dose relative to primary series during a period of Omicron circulation
